Directed and efficient generation of calretinin interneurons from human pluripotent stem cells

利用人类多能干细胞定向高效地生成钙视网膜蛋白中间神经元

阅读:3
作者:Xuewei Du # ,Renli Qi # ,Congge Li ,Wenpei Zhou ,Shijiao Wang ,Shenxing Wei ,Runzhong Wu ,Yu Yin ,Tianqing Li ,Xiaoqing Zhu

Abstract

Background: Schizophrenia, autism, and epilepsy are associated with dysfunctions in cortical GABAergic interneurons. Calretinin-expressing interneurons, the most prominent type, constitute approximately 50% of human cortical GABAergic neurons and are closely linked to cognition. However, the difficulty in obtaining sufficient calretinin interneurons has significantly hindered the study of their development and functions. This study focuses on building an efficient protocol for generating calretinin interneurons, which is key to the brain development and regenerative medicine. Methods: Neuroepithelial stem cells (NESCs) were firstly generated from human pluripotent stem cells (hPSCs) using a previously established protocol, and subsequently treated with sonic hedgehog (SHH), purmorphamine and IWP2 to induce differentiation into calretinin interneurons. Single-cell RNA sequencing (scRNA-seq) was employed to analyze the transcriptional profiles of these interneurons, while their functional properties were assessed via transplantation. Results: We developed a robust protocol enabling the generation of approximately 80% calretinin interneurons from human pluripotent stem cells (hPSCs). NESCs were induced from hPSCs and differentiated into calretinin interneurons through modulation of Shh and Wnt signaling. These interneurons exhibited robust GABAergic action potentials. Upon transplantation, they successfully integrated into the mouse brain and matured into calretinin interneurons. Conclusion: Our study presents an efficient protocol for generating calretinin interneurons from hPSCs, offering a valuable tool for investigating the development of calretinin interneurons. This approach holds potential for applications in regenerative medicine, disease modeling, and drug screening.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。